@prefix this: . @prefix sub: . @prefix beldoc: . @prefix rdfs: . @prefix rdf: . @prefix xsd: . @prefix dct: . @prefix dce: . @prefix pav: . @prefix np: . @prefix belv: . @prefix prov: . @prefix go: . @prefix Protein: . @prefix mgi: . @prefix geneProductOf: . @prefix hasAgent: . @prefix chebi: . @prefix pfm: . @prefix mesh: . @prefix occursIn: . @prefix species: . @prefix pubmed: . @prefix orcid: . sub:Head { this: np:hasAssertion sub:assertion; np:hasProvenance sub:provenance; np:hasPublicationInfo sub:pubinfo; a np:Nanopublication . } sub:assertion { sub:_1 hasAgent: sub:_2; a go:0003824 . sub:_2 geneProductOf: mgi:1339752; a Protein: . sub:_3 hasAgent: sub:_4; a go:0016301 . sub:_4 geneProductOf: pfm:MAPK%20Erk1%2F3%20Family; a Protein: . sub:_5 rdf:object sub:_3; rdf:predicate belv:increases; rdf:subject chebi:6494; a rdf:Statement . sub:_6 occursIn: mesh:D008168, species:10090; rdf:object sub:_5; rdf:predicate belv:increases; rdf:subject sub:_1; a rdf:Statement . sub:assertion rdfs:label "a(CHEBI:lipopolysaccharide) -> kin(p(PFM:\"MAPK Erk1/3 Family\"))", "cat(p(MGI:Csf2)) -> (a(CHEBI:lipopolysaccharide) -> kin(p(PFM:\"MAPK Erk1/3 Family\")))" . } sub:provenance { beldoc: dce:description "Approximately 61,000 statements."; dce:rights "Copyright (c) 2011-2012, Selventa. All rights reserved."; dce:title "BEL Framework Large Corpus Document"; pav:authoredBy sub:_8; pav:version "1.4" . sub:_7 prov:value "Anti-GM-CSF elevated basal Erk1/2 activity, which is consistent with the profile for AP-1. Notably, however, maximal activation of Erk1/2 in response to LPS challenge was suppressed."; prov:wasQuotedFrom pubmed:12208854 . sub:_8 rdfs:label "Selventa" . sub:assertion prov:hadPrimarySource pubmed:12208854; prov:wasDerivedFrom beldoc:, sub:_7 . } sub:pubinfo { this: dct:created "2014-07-03T14:30:05.431+02:00"^^xsd:dateTime; pav:createdBy orcid:0000-0001-6818-334X, orcid:0000-0002-1267-0234 . }